Literature DB >> 19549824

Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins.

Lesley J Page1, Ji Young Suk, Lyudmila Bazhenova, Sheila M Fleming, Malcolm Wood, Yun Jiang, Ling T Guo, Andrew P Mizisin, Robert Kisilevsky, G Diane Shelton, William E Balch, Jeffery W Kelly.   

Abstract

Familial amyloidosis of Finnish type (FAF) is a systemic amyloid disease associated with the deposition of proteolytic fragments of mutant (D187N/Y) plasma gelsolin. We report a mouse model of FAF featuring a muscle-specific promoter to drive D187N gelsolin synthesis. This model recapitulates the aberrant endoproteolytic cascade and the aging-associated extracellular amyloid deposition of FAF. Amyloidogenesis is observed only in tissues synthesizing human D187N gelsolin, despite the presence of full-length D187N gelsolin and its 68-kDa cleavage product in blood-demonstrating the importance of local synthesis in FAF. Loss of muscle strength was progressive in homozygous D187N gelsolin mice. The presence of misfolding-prone D187N gelsolin appears to exacerbate the age-associated decline in cellular protein homeostasis (proteostasis), reflected by the intracellular deposition of numerous proteins, a characteristic of the most common degenerative muscle disease of aging humans, sporadic inclusion body myositis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549824      PMCID: PMC2708763          DOI: 10.1073/pnas.0811753106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence.

Authors:  R P Linke
Journal:  Virchows Arch       Date:  2000-05       Impact factor: 4.064

2.  Role of proprotein convertases in the pathogenic processing of the amyloidosis-associated form of secretory gelsolin.

Authors:  Hannele Kangas; Nabil G Seidah; Tiina Paunio
Journal:  Amyloid       Date:  2002-06       Impact factor: 7.141

3.  Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization.

Authors:  C D Chen; M E Huff; J Matteson; L Page; R Phillips; J W Kelly; W E Balch
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

4.  Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.

Authors:  Michael C Sugarman; Tritia R Yamasaki; Salvatore Oddo; Julio C Echegoyen; M Paul Murphy; Todd E Golde; Mehrdad Jannatipour; Malcolm A Leissring; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  Gelsolin domain 2 Ca2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of finnish type.

Authors:  Mary E Huff; Lesley J Page; William E Balch; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2003-11-14       Impact factor: 5.469

6.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.

Authors:  James F Morley; Heather R Brignull; Jill J Weyers; Richard I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

7.  Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction.

Authors:  Patricia A Rothenbach; Benny Dahl; Jason J Schwartz; Grant E O'Keefe; Masaya Yamamoto; William M Lee; Jureta W Horton; Helen L Yin; Richard H Turnage
Journal:  J Appl Physiol (1985)       Date:  2003-05-02

Review 8.  Biological and chemical approaches to diseases of proteostasis deficiency.

Authors:  Evan T Powers; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly; William E Balch
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Neuromuscular pathology in hereditary gelsolin amyloidosis.

Authors:  Sari Kiuru-Enari; Hannu Somer; Anna-Maria Seppäläinen; Irma-Leena Notkola; Matti Haltia
Journal:  J Neuropathol Exp Neurol       Date:  2002-06       Impact factor: 3.685

10.  Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle.

Authors:  Valerie Askanas; W King Engel; Janis McFerrin; Gaetano Vattemi
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

View more
  21 in total

1.  Discovery and characterization of a mammalian amyloid disaggregation activity.

Authors:  Amber N Murray; James P Solomon; Ya-Juan Wang; William E Balch; Jeffery W Kelly
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

Review 2.  Proteostasis strategies for restoring alpha1-antitrypsin deficiency.

Authors:  Marion Bouchecareilh; Juliana J Conkright; William E Balch
Journal:  Proc Am Thorac Soc       Date:  2010-11

3.  A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.

Authors:  Sungwook Choi; Natàlia Reixach; Stephen Connelly; Steven M Johnson; Ian A Wilson; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2010-02-03       Impact factor: 15.419

4.  Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model.

Authors:  Wouter Van Overbeke; Adriaan Verhelle; Inge Everaert; Olivier Zwaenepoel; Joël Vandekerckhove; Claude Cuvelier; Wim Derave; Jan Gettemans
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

5.  Protein folding: Protection from the outside.

Authors:  Evan T Powers; William E Balch
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

6.  A kinetic aggregation assay allowing selective and sensitive amyloid-β quantification in cells and tissues.

Authors:  Deguo Du; Amber N Murray; Ehud Cohen; Hyun-Eui Kim; Ryan Simkovsky; Andrew Dillin; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-01-26       Impact factor: 3.162

Review 7.  Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention.

Authors:  James P Solomon; Lesley J Page; William E Balch; Jeffery W Kelly
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-24       Impact factor: 8.250

8.  Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.

Authors:  Sergei I Bannykh; William E Balch; Jeffery W Kelly; Lesley J Page; G Diane Shelton
Journal:  Ultrastruct Pathol       Date:  2013-10       Impact factor: 1.094

9.  The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic.

Authors:  James P Solomon; Isaac T Yonemoto; Amber N Murray; Joshua L Price; Evan T Powers; William E Balch; Jeffery W Kelly
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

10.  Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using 99mTc-Modified Nanobodies and SPECT/CT.

Authors:  Adriaan Verhelle; Wouter Van Overbeke; Cindy Peleman; Rebecca De Smet; Olivier Zwaenepoel; Tony Lahoutte; Jo Van Dorpe; Nick Devoogdt; Jan Gettemans
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.